Concomitant coronary and renal revascularization improves left ventricular hypertrophy more than coronary stenting alone in patients with ischemic heart and renal disease

Percutaneous transluminal renal artery stenting (PTRAS) has been proved to have no more benefit than medication alone in treating atherosclerotic renal artery stenosis (ARAS). Whether PTRAS could improve left ventricular hypertrophy (LVH) and reduce adverse events when based on percutaneous coronary...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Zhejiang Univ Sci B
Hlavní autoři: Dong, Hao-jian, Huang, Cheng, Luo, De-mou, Ye, Jing-guang, Yang, Jun-qing, Li, Guang, Luo, Jian-fang, Zhou, Ying-ling
Médium: Artigo
Jazyk:Inglês
Vydáno: Zhejiang University Press 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4710842/
https://ncbi.nlm.nih.gov/pubmed/26739528
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1631/jzus.B1500071
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky